transforming medical diagnostics. - rutherforddiagnostics.co.uk · collaborative partnerships...
TRANSCRIPT
Diagnostics
A progressive approach for a better future
At Rutherford Diagnostics, we believe the provision of optimal, cost-effective diagnostic services and investing
in new and developing technologies is an important step forward in a future where people will
live well for longer.
TRANSFORMINGMEDICAL
DIAGNOSTICS.
By utilising and developing innovative technologies, such as genomic sequencing,
personalised screening and state-of-the-art diagnostics
to reduce levels of acute illness and support good health,
Rutherford Diagnostics will revolutionise healthcare.
0151 702 9489rutherforddiagnostics.co.uk
From genomics...
Rutherford Diagnostics is investing and facilitating, at scale, the progression
of genomics (the recording of whole genome sequence data). Genomics will play an
important part in ensuring a future where personalised medicine through genetic testing will
predict disease, susceptibility and drug response.
We will fund, deliver and maintain state-of-the-art diagnostic equipment housed in modern and well-designed facilities, and will seek
out and will be open to investing in commonly unattainable and novel diagnostic technologies that will benefit the nation’s health outcomes.
To diagnostics...
Our team is proficient in the agile implementation and management of complex healthcare technologies and we share a vision of a future where,
through prevention, prediction and earliest diagnoses, people will live well for longer.
CT
PET/CT
MR
Ultrasound
Endoscopy
Genomics
Screening
Research and Education
The core services andtechnologies
Rutherford Diagnostics will provide include:
Collaborative partnerships
Rutherford Diagnostics believes that working collaboratively is the most effective way of ensuring a healthier and more cost-effective future.
By building partnerships with healthcare professionals and organisations and providing them with a much needed diagnostic capacity that utilises the most
advanced equipment available, Rutherford Diagnostics aims to support their longer-term aspirations of delivering high quality healthcare and
outcomes to communities.
We will work closely with our partners to deliver bespoke, flexible diagnostic services that genuinely make a difference and fulfil a local need. We also aim
to support appropriate non-diagnostic healthcare needs where possible.
Led by an expert team
Our team is proficient in the agile implementation and management of complex healthcare technologies and we share a vision of a future where,
through prevention, prediction and earliest diagnoses, people will live well for longer.
Rutherford Diagnostics is led by a team of industry experts with a track record of delivery in the healthcare sector.
0800 210 0402rutherfordiagnostics.co.uk
© Copyright 2018: Rutherford Diagnostics Ltd, is a wholly owned subsidiary of Proton Partners International Ltd. The Copyright in this work is vested in Proton Partners International Limited. The document is issued in confidence solely for the purposes for which it is supplied. Reproduction in whole or in part or use for tendering or marketing purposes is prohibited
except with the written consent of Proton Partners International Limited and then only on the condition that this notice is included in any such reproduction.
CORP-DIAG-PI03
Rutherford Diagnostics Ltd0151 702 9489 | [email protected] | rutherforddiagnostics.co.uk
Accelerator, 1 Daulby Street, Liverpool, L7 8XZ
Diagnostics
Rutherford Diagnostics is a subsidiary of Proton Partners International which operates a network of cancer centres and, through diagnostic imaging, chemotherapy, radiotherapy and proton therapy, aims to provide all-encompassing cancer services for patients.
Together Rutherford Diagnostics and Proton Partners International share a common vision to deliver the very best health outcomes possible to communities across the UK and globally.
Rutherford Diagnosticsis at the forefront of healthcare transformation.